(2014). Correction to “A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses”. The American Society for Pharmacology and Experimental Therapeutics.
Citación estilo ChicagoCorrection to “A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT2B Inverse Agonist With Preclinical Efficacy for Psychoses”. The American Society for Pharmacology and Experimental Therapeutics, 2014.
Cita MLACorrection to “A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT2B Inverse Agonist With Preclinical Efficacy for Psychoses”. The American Society for Pharmacology and Experimental Therapeutics, 2014.